Post

New research · Ophthalmology
Life (Basel, Switzerland) · 1d
ReviewLife (Basel, Switzerland) · 2026

Management of Retinoblastoma: A Challenge in Pediatric Ophthalmology.

Claudia Carolina Cruz-Gálvez, Víctor Manuel Villar-Calvo, Juan Carlos Ordaz-Favila … Vanessa Bosch-Canto
Read paper
OphthalmologyReview

Timely detection and proper treatment give retinoblastoma patients up to 98% survival.

Management of Retinoblastoma: A Challenge in Pediatric Ophthalmology.

Claudia Carolina Cruz-Gálvez … Vanessa Bosch-Canto
Life (Basel, Switzerland) · 2026
Background

Retinoblastoma (Rb) is the most common intraocular malignancy.

Results
98%
children whose retinoblastoma is caught and treated early usually survive
More results

If left untreated, Rb can result in death within 1-2 years.

The primary goal of Rb treatment is to eliminate cancer and save the patient's life, while the second goal includes preserving the eye and vision.

There are several treatment options available for Rb.

More results

The PubMed database was utilized to identify relevant references published during the last 35 years.

“
Conclusion

This article shows basic and current concepts on managing Rb, which encompasses diagnosis, evaluation, treatment, follow-up, and challenges.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving